Skip to main content
In stock|Targeted Therapy

Glumetinib

Oncology TypeSolid Tumour
Drug Class / MechanismMET Inhibitor
No Image
Description

Glumetinib is classified as a MET Inhibitor, sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy
Oncology TypeSolid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3